Login / Signup
Hans Jakob Hartling
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 2
Top Topics
Phase Iii
Prognostic Factors
Ejection Fraction
Chronic Lymphocytic Leukemia
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Rebecca Svanberg Teglgaard
,
Hanne Vibeke Hansen Marquart
,
Hans Jakob Hartling
,
Jakob Thaning Bay
,
Caspar da Cunha-Bang
,
Christian Brieghel
,
Tereza Faitová
,
Lisbeth Enggaard
,
Arnon P Kater
,
Mark-David Levin
,
Sabina Kersting
,
Sisse Rye Ostrowski
,
Carsten Utoft Niemann
Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Rebecca Svanberg Teglgaard
,
Hanne Vibeke Hansen Marquart
,
Hans Jakob Hartling
,
Jakob Thaning Bay
,
Caspar da Cunha-Bang
,
Christian Brieghel
,
Tereza Faitová
,
Lisbeth Enggaard
,
Arnon P Kater
,
Mark-David Levin
,
Sabina Kersting
,
Sisse Rye Ostrowski
,
Carsten Utoft Niemann
Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (9) (2024)